In This Section

NextGen Stars

PLEASE NOTE: The AACR Board of Directors has decided to convene the AACR Annual Meeting 2021 in a virtual format.

View the Statement
Read the Virtual Meeting FAQ

NextGen Star applications are now closed. The deadline was 12:00 p.m. ET, Tuesday, October 13, 2020.

The AACR invites Associate Members and early-career Active members to apply to be a NextGen Star and give a talk in a major session at the AACR Annual Meeting 2021. The following rules apply: 

  • Applicants must be AACR Associate Members or Active Members who are not above the level of Assistant Professor or equivalent. Please note that you must be an AACR member in good standing (dues paid for the current year) in order to submit an application. Applicants who do not meet these criteria will not be able to apply. Nonmembers are encouraged to apply for AACR membership. You may either submit the Official AACR Membership Application online or download the application and submit it to the AACR office with the required documents. Please allow 30 days for application review and approval notification. Visit www.aacr.org/Membership or contact [email protected] with any questions. 
  • Applications consist of an extended abstract (limit 8,000 characters including spaces), a CV, and a letter of recommendation from your P.I., department head, or another mentor who is familiar with your work. Only complete applications will be considered. The application deadline is 12:00 p.m. ET, Tuesday, October 13, 2020. No late applications will be considered. All applications must be submitted online through myAACR. 
  • Between 8 and 12 applicants will be chosen to give a talk, regardless of the number of applications received. 
  • Selected talks will be added to existing Major Symposia and Advances sessions, based on the subject matter of the abstract. Most talks will be 15 minutes in length plus 5 minutes for discussion, but the assigned length of the talk may vary depending on the session. 
  • Applicants who are selected to give talks at the Annual Meeting will receive travel support and complimentary registration for the meeting. 
  • The submission of an extended abstract through this application process is completely separate from the submission of a regular abstract for the Annual Meeting. Applicants will be notified of their status by early November. Those who are not selected to give a talk, but still wish to submit an abstract to the Annual Meeting, must submit a separate abstract through the normal abstract submission process by the Thursday, November 19, 2020 deadline. 

NextGen Stars 2020

Uri Ben-David, PhD

Uri Ben-David, PhD

Assistant Professor, Department of Human Molecular Genetics and Biochemistry
Tel Aviv University, Tel Aviv, Israel
Genomic evolution of cancer models: perils and opportunities

Joshua J. Breunig, PhD

Joshua J. Breunig, PhD

Assistant Professor, Department of Biomedical Sciences
Cedars-Sinai Medical Center, Los Angeles, California
MADR: rapid generation of somatic mosaics with locus-specific, stably-integrated transgenic elements for generation of “personalized” mouse models and human organoid tumor models

Marios Giannakis, MD, PhD

Marios Giannakis, MD, PhD

Assistant Professor of Medicine, Medical Oncology
Dana-Farber Cancer Institute, Boston, Massachusetts
Metabolomic adaptations and correlates of survival to immune checkpoint blockade

Lee D. Gibbs, PhD

Lee D. Gibbs, PhD

Postdoctoral Fellow, Department of Translational Genomics
Keck School of Medicine of University of Southern California, Los Angeles, California
Spatial RNA-seq reveals intra-tumor heterogeneity and transcriptional substructure in high grade ovarian cancers

Sheng Li, PhD

Sheng Li, PhD

Assistant Professor, Genomic Medicine
The Jackson Laboratory, Farmington, Connecticut
Somatic mutations drive specific, but reversible epigenetic heterogeneity states in AML

Ping Mu, PhD

Ping Mu, PhD

Assistant Professor, Department of Molecular Biology
The University of Texas Southwestern Medical Center, Dallas, Texas
CHD1-Loss confers AR targeted therapy resistance via promoting cancer heterogeneity and lineage plasticity

Maeve Mullooly, PhD, MPH

Maeve Mullooly, PhD, MPH

Research Fellow, Division of Population Health Sciences
Royal College of Surgeons in Ireland, Dublin, Ireland
Investigation of relationships between breast cancer risk factors and bilateral mammographic breast density asymmetry among women undergoing diagnostic image-guided breast biopsies

Cristina Puig-Saus, PhD

Cristina Puig-Saus, PhD

Associate Project Scientist, Division of Hematology-Oncology
University of California, Los Angeles, Los Angeles, California
Landscape analysis of neoepitope-specific T cell responses to immunotherapy

Nidhi Sahni, PhD

Nidhi Sahni, PhD

Assistant Professor, Department of Epigenetics and Molecular Carcinogenesis

The University of Texas MD Anderson Cancer Center, Smithville, Texas
Proteome instability is an immunogenic therapeutic vulnerability in mismatch repair deficient cancer

Ingunn Stromnes, PhD

Ingunn Stromnes, PhD

Assistant Professor, Department of Microbiology and Immunology
University of Minnesota, Minneapolis, Minnesota
Combination CD40 agonist and anti-PD-L1 eradicate pancreatic ductal adenocarcinoma by expanding type I dendritic cells, altering cytokine and chemokine production, and promoting intratumoral KLRG1+ tumor-specific T cells

Neil Vasan, MD, PhD

Neil Vasan, MD, PhD

Assistant Attending Physician
Memorial Sloan Kettering Cancer Center, New York, New York
Double PIK3CA mutations in cis increase oncogenicity and sensitivity to PI3Kα inhibitors

Liling Wan, PhD

Liling Wan, PhD

Assistant Professor, Department of Cancer Biology
University of Pennsylvania, Philadelphia, Pennsylvania
Gain-of-function mutations in histone acetylation reader ENL in human cancer